Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors

Journal of Neuro-Oncology

Volumn 116, Issue 1, 2014, Pages 161-168

  Habets, Esther J J ^a   Taphoorn, Martin J B ^a,b   Nederend, Sylvie ^b   Klein, Martin ^b   Delgadillo, Daniel ^c   Hoang Xuan, Khê ^c   Bottomley, Andrew ^d   Allgeier, Anouk ^d   Seute, Tatjana ^e   Gijtenbeek, Anja M M ^f   De Gans, Jan ^g   Enting, Roelien H ^h   Tijssen, Cees C ⁱ   Van Den Bent, Martin J ^j   Reijneveld, Jaap C ^b,g  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d EORTC DATA CENTER   (Belgium)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^j ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Anaplastic oligoastrocytoma; Anaplastic oligodendroglioma; Cognitive functioning; Quality of life

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITION; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; MOOD; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; QUALITY OF LIFE QUESTIONNAIRE; QUESTIONNAIRE;

AGED; ASTROCYTOMA; BRAIN NEOPLASMS; COGNITION DISORDERS; COHORT STUDIES; DACARBAZINE; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; RADIOTHERAPY; STATISTICS, NONPARAMETRIC; SURVIVORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84891829239     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1278-0     Document Type: Article

References (36)

1. van den Bent MJ, Brandes AA, Taphoorn MJ et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344-350
2. Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9,402. J Clin Oncol 31:337-343
3. Hamlat A, Saikali S, Chaperon J et al (2006) Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas. J Neurooncol 79:159-168
4. Sant M, Minicozzi P, Lagorio S, Borge JT, Marcos-Gragera R, Francisci S (2012) Survival of European patients with central nervous system tumors. Int J Cancer 131:173-185
5. Steinbach JP, Blaicher HP, Herrlinger U et al (2006) Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology 66:239-242
6. Flechl B, Ackerl M, Sax C et al (2012) Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neurooncol 109:331-339
7. Wang M, Cairncross G, Shaw E et al (2010) Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Int J Radiat Oncol Biol Phys 77:662-669
8. Taphoorn MJ, van den Bent MJ, Mauer ME et al (2007) Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol 25:5723-5730
9. Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324-333
10. Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19:4037-4047
11. Meyers CA, Cantor SB (2003) Neuropsychological assessment and treatment of patients with malignant brain tumors. In: Prigatano GP, Pliskin NH (eds) Clinical neuropsychology and cost outcome research: a beginning. Psychology Press Inc., New York, pp 159-173
12. Douw L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810-818
13. Jolles J, van Boxtel MP, Ponds RW, Metsemakers JF, Houx PJ (1998) The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging. Tijdschr Gerontol Geriatr 29:120-129
14. De Bie SE (1987) Voorstellen voor uniformering van vraagstellingen naar achtergrondkenmerken en interviews [Proposal for uniformisation of questions regarding background variables and interviews]. Leiden University Press, Leiden
15. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
16. Osoba D, Aaronson NK, Muller M et al (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139-150
17. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual. European Organisation for Research and Treatment of Cancer, Brussels
18. Schroevers MJ, Sanderman R, Van SE, Ranchor AV (2000) The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res 9:1015-1029
19. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:383-392
20. Sneeuw KC, Aaronson NK, Osoba D et al (1997) The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 35:490-506
21. van de Poll-Franse LV, Mols F, Gundy CM et al (2011) Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 47:667-675
22. de Vries J, Michielsen HJ, Van Heck GL (2003) Assessment of fatigue among working people: a comparison of six questionnaires. Occup Environ Med 60(Suppl 1):i10-i15
23. Ensel WM (1986) Measuring depression: the CES-D scale. In: Lin N, Dean A, Ensel WM (eds) Social support. Life events and depression. Academic Press Inc., Orlando, pp 51-70
24. Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191-205
25. Sachsenheimer W, Piotrowski W, Bimmler T (1992) Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. J Neurooncol 13:177-181
26. Hannay HJ, Lezak ML (2004) The neuropsychological examination: interpretation. In: Lezak MD, Howieson DB, Loring DW (eds) Neuropsychological assessment. Oxford University Press, New York, pp 133-156
27. Bosma I, Vos MJ, Heimans JJ et al (2007) The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol 9:53-62
28. Bosma I, Reijneveld JC, Douw L et al (2009) Health-related quality of life of long-term high-grade glioma survivors. Neuro Oncol 11:51-58
29. van den Bent MJ, Carpentier AF, Brandes AA et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715-2722
30. Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159-168
31. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992-999
32. Scheibel RS, Meyers CA, Levin VA (1996) Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 30:61-69
33. Archibald YM, Lunn D, Ruttan LA et al (1994) Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80:247-253
34. Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361-1368
35. Reijneveld JC, Klein M, Taphoorn MJ, Postma TJ, Heimans JJ (2012) Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning. Pharmacogenomics 13:1667-1669
36. Gehring K, Sitskoorn MM, Gundy CM et al (2009) Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol 27:3712-3722